Scientific

MK5 Microarray Data


Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 718 to 767 of 3228 in total
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1
\def\wcA{0.16666666666667\textwidth} \def\wcB{0.16666666666667\textwidth} \def\wcC{0.16666666666667\textwidth} \def\wcD{0.16666666666667\textwidth} \def\wcE{0.16666666666667\textwidth} \begin{longtable}{|c|c|c|c|c|} \hline \parbox{\wcA}{\vspace{3pt}\noindent Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent network\_comparison\vspace{3pt}}\\ \hline \hline \parbox{\wcA}{\vspace{3pt}\noindent 718\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent cpz gene product. [source:refseq;acc:nm\_003652]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 6593.17\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 7364.55\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.117\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 719\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent carboxypeptidase h precursor (ec 3.4.17.10) (cph) (carboxypeptidase e) (cpe) (enkephalin convertase) (prohormone processing carboxypeptidase). [source:swissprot;acc:p16870]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 720\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent potential carboxypeptidase x precursor (ec 3.4.17.-) (metallocarboxypeptidase cpx-1). [source:swissprot;acc:q96sm3]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 721\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent syntaxin 7. [source:swissprot;acc:o15400]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5580.97\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6233.52\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.11692\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 722\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent histidyl-trna synthetase homolog (ec 6.1.1.21) (histidine--trna ligase homolog) (hisrs). [source:swissprot;acc:p49590]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 8061.05\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 9002.33\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.11677\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 723\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent histidyl-trna synthetase (ec 6.1.1.21) (histidine--trna ligase) (hisrs). [source:swissprot;acc:p12081]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 8056.09\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 8996.46\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.11673\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 724\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent phenylalanyl-trna synthetase alpha chain (ec 6.1.1.20) (phenylalanine- -trna ligase alpha chain) (phers) (cml33). [source:swissprot;acc:q9y285]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 5384.41\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 6012.82\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.11671\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 725\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent phenylalanine-trna synthetase. [source:refseq;acc:nm\_006567]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 726\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent dna mismatch repair protein mlh3 (mutl protein homolog 3). [source:swissprot;acc:q9uhc1]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6327.86\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7064.13\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.11635\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 727\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 60s ribosomal protein l24 (l30). [source:swissprot;acc:p38663]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 7087.23\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7911.25\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.11627\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 728\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent hcv ns3-transactivated protein 1. [source:refseq;acc:nm\_019048]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 6000.23\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 6696.89\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.11611\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 729\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent vacuolar atp synthase catalytic subunit a, ubiquitous isoform (ec 3.6.3.14) (v-atpase a subunit 1) (vacuolar proton pump alpha subunit 1) (v-atpase 69 kda subunit 1) (isoform va68). [source:swissprot;acc:p38606]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 730\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent asparagine synthetase [glutamine-hydrolyzing] (ec 6.3.5.4) (glutamine- dependent asparagine synthetase) (ts11 cell cycle control protein). [source:swissprot;acc:p08243]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 731\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent methyltransferase like 2. [source:refseq;acc:nm\_018396]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 13241.4\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 11864\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.1161\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 732\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent cytoplasmic dynein light chain (t-complex testis-specific protein 1 homolog) (protein cw-1). [source:swissprot;acc:q15763]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 733\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent fzr1 protein; fizzy-related protein; cdc20-like 1b. [source:refseq;acc:nm\_016263]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 734\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent proprotein convertase subtilisin/kexin type 5 precursor (ec 3.4.21.-) (proprotein convertase pc5) (subtilisin/kexin-like protease pc5) (convertase pc5) (pc6) (hpc6). [source:swissprot;acc:q92824]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 735\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent vacuolar atp synthase 16 kda proteolipid subunit (ec 3.6.3.14). [source:swissprot;acc:p27449]\vspace{3pt}}&\multirow{7}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 5768.32\vspace{3pt}}}&\multirow{7}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 6434.78\vspace{3pt}}}&\multirow{7}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.11554\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 736\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent sarcoglycan zeta; zeta-sarcoglycan. [source:refseq;acc:nm\_139167]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 737\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent golgi complex associated protein 1; golgi resident protein gcp60; peripherial benzodiazepine receptor associated protein; golgi phosphoprotein 1; pbr associated protein; pka (rialpha)-associated protein. [source:refseq;acc:nm\_022735]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 738\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent delta-sarcoglycan (sg-delta) (35 kda dystrophin-associated glycoprotein) (35dag). [source:swissprot;acc:q92629]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 739\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent cellular modulator of immune recognition. [source:refseq;acc:nm\_145021]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 740\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent vacuolar atp synthase 21 kda proteolipid subunit (ec 3.6.3.14) (hatpl). [source:swissprot;acc:q99437]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 741\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent gamma-sarcoglycan (gamma-sg) (35 kda dystrophin-associated glycoprotein) (35dag). [source:swissprot;acc:q13326]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 742\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent eukaryotic translation initiation factor 3 subunit 4 (eif-3 delta) (eif3 p44) (eif-3 rna-binding subunit) (eif3 p42) (eif3g). [source:swissprot;acc:o75821]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 4131.04\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 4607.9\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.11543\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 743\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent eukaryotic translation initiation factor 3 subunit 10 (eif-3 theta) (eif3 p167) (eif3 p180) (eif3 p185) (eif3a). [source:swissprot;acc:q14152]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 744\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent cytidine triphosphate synthase ii; ctp synthetase type 2; utp-ammonia ligase; ctp synthetase isoform; cytidine 5'-triphosphate synthetase 2. [source:refseq;acc:nm\_019857]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 12515.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 11221.1\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.11535\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 745\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent neuroepithelial cell transforming gene 1; guanine nucleotide regulatory protein (oncogene); rho guanine nucleotide exchange factor (gef) 8. [source:refseq;acc:nm\_005863]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 4086.6\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 4557.68\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.11527\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 746\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent rho guanine nucleotide exchange factor 3; rhogef protein; 59.8 kda protein; exchange factor found in platelets and leukemic and neuronal tissues, xpln. [source:refseq;acc:nm\_019555]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 747\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent down-regulated in metastasis. [source:refseq;acc:nm\_014503]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 748\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ctp synthase (ec 6.3.4.2) (utp--ammonia ligase) (ctp synthetase). [source:swissprot;acc:p17812]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 12503.3\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 11212\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.11517\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 749\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ethanolamine-phosphate cytidylyltransferase (ec 2.7.7.14) (phosphorylethanolamine transferase) (ctp:phosphoethanolamine cytidylyltransferase). [source:swissprot;acc:q99447]\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcC}{\vspace{3pt}\noindent 4565.34\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcD}{\vspace{3pt}\noindent 5085.92\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcE}{\vspace{3pt}\noindent 1.11403\vspace{3pt}}}\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 750\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent myosin light chain 1, skeletal muscle isoform (mlc1f) (a1 catalytic) (alkali). [source:swissprot;acc:p05976]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 751\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent myosin light chain 1, slow-twitch muscle b/ventricular isoform (mlc1sb) (alkali). [source:swissprot;acc:p08590]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 752\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent nadh-ubiquinone oxidoreductase 13 kda-a subunit, mitochondrial precursor (ec 1.6.5.3) (ec 1.6.99.3) (complex i-13kd-a) (ci-13kd-a). [source:swissprot;acc:o75380]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 753\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent myosin light chain 1, slow-twitch muscle a isoform (mlc1sa) (alkali). [source:swissprot;acc:p14649]\vspace{3pt}}&&&\\\cline{1-2} \parbox{\wcA}{\vspace{3pt}\noindent 754\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent myosin light chain 1, embryonic muscle/atrial isoform (pro1957). [source:swissprot;acc:p12829]\vspace{3pt}}&&&\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 755\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent nucleolar rna-associated protein alpha isoform. [source:refseq;acc:nm\_022917]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4079.81\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 4545.01\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.11402\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 756\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent topoisomerase-related function protein 4-2. [source:refseq;acc:nm\_022447]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4725.28\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5261.06\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.11339\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 757\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent signal recognition particle 68 kda protein (srp68). [source:swissprot;acc:q9uhb9]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5622.89\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6260.02\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.11331\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 758\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent dna polymerase epsilon subunit b (ec 2.7.7.7) (dna polymerase ii subunit b). [source:swissprot;acc:p56282]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 3760.3\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 4185.82\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.11316\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 759\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 6-phosphofructokinase, type c (ec 2.7.1.11) (phosphofructokinase 1) (phosphohexokinase) (phosphofructo-1-kinase isozyme c) (pfk-c) (6-phosphofructokinase, platelet type). [source:swissprot;acc:q01813]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4254.62\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 4736.03\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.11315\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 760\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent atpase, h+ transporting, lysosomal 38kda, v0 subunit d isoform 2. [source:refseq;acc:nm\_152565]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5870.2\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6533.39\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.11298\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 761\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent translation initiation factor if-2. [source:swissprot;acc:o60841]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 5811.51\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6467.62\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.1129\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 762\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent pms1 protein homolog 2 (dna mismatch repair protein pms2). [source:swissprot;acc:p54278]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6231.31\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 6933.9\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.11275\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 763\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 6-phosphofructokinase, muscle type (ec 2.7.1.11) (phosphofructokinase 1) (phosphohexokinase) (phosphofructo-1-kinase isozyme a) (pfk-a) (phosphofructokinase-m). [source:swissprot;acc:p08237]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4250.54\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 4729.67\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.11272\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 764\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent 6-phosphofructokinase, liver type (ec 2.7.1.11) (phosphofructokinase 1) (phosphohexokinase) (phosphofructo-1-kinase isozyme b) (pfk-b). [source:swissprot;acc:p17858]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4250.18\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 4729.12\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.11269\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 765\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent polymerase (dna directed) sigma; topoisomerase-related function protein 4-1; polymerase (dna-directed) sigma. [source:refseq;acc:nm\_006999]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 4726.38\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 5258.95\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.11268\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 766\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent ubiquitin-conjugating enzyme e2 variant 1 isoform b; dna-binding protein. [source:refseq;acc:nm\_003349]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6691.93\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7445.09\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.11255\vspace{3pt}}\\\hline \parbox{\wcA}{\vspace{3pt}\noindent 767\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent utp--glucose-1-phosphate uridylyltransferase 2 (ec 2.7.7.9) (udp- glucose pyrophosphorylase 2) (udpgp 2) (ugpase 2). [source:swissprot;acc:q16851]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent 6691.21\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent 7444.22\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent 1.11254\vspace{3pt}}\\\hline nd{longtable}
Legend:
- Rank is the rank after comparing the two networks
- Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray
- Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.
- Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them
- Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.
- Filtered specifies whether we only included the high confidence microarry measurements or not.

- http://analysis.yellowcouch.org/